The Homeopathic Medicinal Products Working Group (HMPWG) of the Heads of Medicines Agency (HMA) seeks to publish lists of stocks for which homeopathic use is justified. The first list was published in 2013, the second in April 2015 and the third in August 2015; this latter includes 40 different stocks.
These are non-exhaustive lists of homeopathic stocks whose homeopathic use is considered satisfactorily justified by the HMPWG. The list is comprised of:
- the name(s) of the stocks including the Latin name
- a Pharmacopoeia reference (the European Pharmacopoeia (Ph. Eur.) or in absence thereof a Pharmacopoeia currently used officially in the member states)
- definition of the raw material.
It is the intention that these lists will act as a reliable reference document for applications for special, simplified registration of homeopathic medicinal products, which require the justification for homeopathic use of a stock on the basis of an adequate bibliography. It is hoped that this will significantly simplify the documentation effort for both applicants and the competent authorities.